Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Form 8-K — Oct 22, 2026

Shuttle Pharmaceuticals Holdings (SHPH) dismissed its auditor Forvis Mazars, LLP on October 16, 2026, effective after the filing of its 10-Q for the quarter ended September 30, 2026. The dismissal follows previously disclosed material weaknesses in internal control over financial reporting, including limited accounting policies, segregation-of-duties failures, IT general control issues, and entity-level control deficiencies. Forvis Mazars's prior audit reports also included a going-concern explanatory paragraph. Notably, the Company has not yet engaged a successor auditor, and Forvis Mazars confirmed it agrees with the Company's disclosures in its Exhibit 16.1 letter.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.